Potential for application of hydroxyapatite-based bone grafting materials in spine surgery

U. Mukhametov, S. Lyulin, D. Borzunov
{"title":"Potential for application of hydroxyapatite-based bone grafting materials in spine surgery","authors":"U. Mukhametov, S. Lyulin, D. Borzunov","doi":"10.24060/2076-3093-2022-12-4-337-344","DOIUrl":null,"url":null,"abstract":"The expansion in the number of primary joint replacements worldwide is causing a rise in revision joint replacements due to bacterial infection. Revision surgery with cementless implants appears to be beneficial for long-term outcome, and using antibiotic-impregnated bone grafts can control infection and provide good implant support. Autologous bone graft s (autografts) areused in surgery to fill defects and impaction bone grafting in spinal reconstruction. Because of their superior osteoinductive ability, autograft sare considered the “gold standard” for these treatments. However, due to a better cost-benefit ratio, allografts are also often used. In case of limited donor availability for autologous or allogeneic bone graft s, bone grafting materials are a reasonable alternative or adjunct. Bone grafting materials combine or are based on different substances. Growth factors of the bone morphogenetic protein family are recombinant proteins that specifically induce bone and cartilage growth. One advantage of bone grafting materials is that they can be combined with several antibiotics. Th e choice of antibiotics should consider possible dose-dependent cellular and pharmacological side effects at the implantation site, as well as be based on antimicrobial efficacy. Thus, microbiologists, pharmacologists and surgeons must decide together which combination is more appropriate. Bone grafting materials with active ingredient supplements are considered to be combination drugs, characterised by a primary effect (bone replacement function) and a secondary effect (prevention of bacterial recolonization of the bone grafting materials). Both functions must be clinically validated during the registration process as a Class III medical device. Currently, only a few combination products are available on the market. In this review, we considered the existing hydroxyapatite-based bone grafting materials and the potential for their use in spine surgery.","PeriodicalId":52846,"journal":{"name":"Kreativnaia khirurgiia i onkologiia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kreativnaia khirurgiia i onkologiia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24060/2076-3093-2022-12-4-337-344","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The expansion in the number of primary joint replacements worldwide is causing a rise in revision joint replacements due to bacterial infection. Revision surgery with cementless implants appears to be beneficial for long-term outcome, and using antibiotic-impregnated bone grafts can control infection and provide good implant support. Autologous bone graft s (autografts) areused in surgery to fill defects and impaction bone grafting in spinal reconstruction. Because of their superior osteoinductive ability, autograft sare considered the “gold standard” for these treatments. However, due to a better cost-benefit ratio, allografts are also often used. In case of limited donor availability for autologous or allogeneic bone graft s, bone grafting materials are a reasonable alternative or adjunct. Bone grafting materials combine or are based on different substances. Growth factors of the bone morphogenetic protein family are recombinant proteins that specifically induce bone and cartilage growth. One advantage of bone grafting materials is that they can be combined with several antibiotics. Th e choice of antibiotics should consider possible dose-dependent cellular and pharmacological side effects at the implantation site, as well as be based on antimicrobial efficacy. Thus, microbiologists, pharmacologists and surgeons must decide together which combination is more appropriate. Bone grafting materials with active ingredient supplements are considered to be combination drugs, characterised by a primary effect (bone replacement function) and a secondary effect (prevention of bacterial recolonization of the bone grafting materials). Both functions must be clinically validated during the registration process as a Class III medical device. Currently, only a few combination products are available on the market. In this review, we considered the existing hydroxyapatite-based bone grafting materials and the potential for their use in spine surgery.
羟基磷灰石基骨移植材料在脊柱外科中的应用潜力
由于细菌感染,全世界原发性关节置换术数量的增加导致翻修关节置换术的增加。非骨水泥植入物的翻修手术似乎有利于长期疗效,使用抗生素浸渍的骨移植物可以控制感染并提供良好的植入物支持。自体骨移植(自体骨移植)在外科手术中用于填充缺损,在脊柱重建中用于嵌塞骨移植。由于其优越的骨诱导能力,自体移植物被认为是这些治疗的“金标准”。然而,由于更好的成本效益比,同种异体移植物也经常被使用。在自体或同种异体骨移植的供体可用性有限的情况下,骨移植材料是一种合理的替代或辅助材料。骨移植材料结合或基于不同的物质。骨形态发生蛋白家族的生长因子是特异性诱导骨和软骨生长的重组蛋白。骨移植材料的一个优点是可以与几种抗生素联合使用。抗生素的选择应考虑植入部位可能存在的剂量依赖性细胞和药理学副作用,并基于抗菌功效。因此,微生物学家、药理学家和外科医生必须共同决定哪种组合更合适。具有活性成分补充剂的骨移植材料被认为是组合药物,其特征是主要作用(骨替代功能)和次要作用(防止骨移植材料的细菌再定植)。这两种功能都必须在注册过程中作为III类医疗器械进行临床验证。目前,市场上只有少数几种组合产品。在这篇综述中,我们考虑了现有的羟基磷灰石基骨移植材料及其在脊柱手术中的应用潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
36
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信